Stock Report

All about this stock under one free report Last Updated: 31-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Vijaya Diagno Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: VIJAYA | BSE: 543350

₹1,503.50

up-down-arrow ₹51.00 (3.51%)

As on 31-Aug-2026 13:54IST

Market cap

info icon

₹15,083 Cr

Revenue (TTM)

info icon

₹857 Cr

P/E Ratio

info icon

80.4

P/B Ratio

info icon

15

Div. Yield

info icon

0.1 %

Edit peer-selector-edit
Vijaya Diagno Global Health Dr. Lal Pathlabs Krishna Institute Metropolis Health
Market cap (₹ Cr)
 15,083 39,667 31,942 31,952 12,015
Revenue (₹ Cr)
 857 4,683 2,891 4,213 1,710
Net Profit (₹ Cr)
 187.49 552.34 546.30 190.80 202.82
Net Margin (%)
 21.32 11.55 18.23 4.49 11.70
RoE (%)
 20.58 14.93 23.03 9.45 14.13
Price to Earnings
 80.45 71.32 58.94 156.40 59.59
Price-To-Book
 14.97 9.65 12.22 8.44 7.71

Income Statement (₹ Cr)

Vijaya Diagno Global Health Dr. Lal Pathlabs Krishna Institute Metropolis Health
Operating Revenue arrow
857.13 4,683.37 2,890.80 4,212.50 1,710.00
Total Income arrow
879.41 4,783.78 2,995.90 4,248.00 1,733.17
Total Expenditure arrow
495.19 3,704.62 2,053.10 3,379.70 1,287.72
EBITDA arrow
361.94 978.75 837.70 832.80 422.28
Depreciation arrow
96.06 246.41 171.60 330.60 135.28
EBIT arrow
265.89 732.34 666.10 502.20 287.00
Interest arrow
36.75 92.01 24.40 253.30 25.53
Other Income arrow
22.28 100.41 105.10 35.50 23.17
Exceptional Items arrow
0.00 -20.61 -30.10 -11.20 -8.99
Profit before Tax arrow
251.42 720.14 716.70 273.20 275.66
Provision for Tax arrow
63.93 167.80 170.40 82.40 72.84
Profit after Tax arrow
187.49 552.34 546.30 190.80 202.82

Liabilities (₹ Cr)

Vijaya Diagno Global Health Dr. Lal Pathlabs Krishna Institute Metropolis Health
Shareholder's Funds arrow
957.15 3,961.57 2,508.20 2,247.40 1,513.16
Minority Interest arrow
0.00 3.84 -4.40 9.90 -1.20
Non-Current Liabilities arrow
426.03 1,293.60 154.00 3,961.30 279.48
Current Liabilities arrow
123.87 627.13 450.70 1,238.90 334.02
Total Liabilities arrow
1,507.05 5,905.00 3,139.97 7,690.70 2,524.76

Assets (₹ Cr)

Vijaya Diagno Global Health Dr. Lal Pathlabs Krishna Institute Metropolis Health
Non-Current Assets arrow
737.24 3,128.95 1,176.30 5,416.90 1,415.30
Current Assets arrow
321.90 1,674.92 1,566.60 937.40 468.61
Total Assets arrow
1,507.05 5,905.00 3,139.97 7,690.70 2,524.76
Total Debt* arrow
0.00 631.08 0.00 3,244.00 18.73
Net Current Assets arrow
198.03 1,047.79 1,115.90 -301.50 134.59
Contingent Liabilities arrow
0.13 100.01 16.76 81.10 10.08

Cashflow (₹ Cr)

Vijaya Diagno Global Health Dr. Lal Pathlabs Krishna Institute Metropolis Health
Cash From Operating Activities arrow
270.59 714.39 635.61 510.80 350.70
Cash Flow from Investing Activities arrow
-174.22 -1,089.11 -421.86 -1,451.70 -223.13
Cash from Financing Activities arrow
-69.49 271.85 -263.57 940.30 -115.29
Net Cash Inflow / Outflow arrow
26.88 -102.87 -49.83 -0.60 12.28

Ratios

Profitability Ratios

 Vijaya Diagno Global Health Dr. Lal Pathlabs Krishna Institute Metropolis Health
ROCE (%) arrow
30.28 19.38 29.56 11.51 20.03
ROE (%) arrow
20.58 14.93 23.03 9.45 14.13
ROA (%) arrow
13.49 10.35 18.64 2.83 10.13
EBIT Margin (%) arrow
31.02 15.64 23.04 11.92 16.78
Net Margin (%) arrow
21.32 11.55 18.23 4.49 11.70
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Vijaya Diagno Global Health Dr. Lal Pathlabs Krishna Institute Metropolis Health
Revenue Growth (%) arrow
20.18 21.27 14.29 30.90 21.80
EBIT Growth (%) arrow
26.22 0.94 15.64 -16.88 43.53
Net Profit Growth (%) arrow
24.27 3.43 5.38 -52.81 32.87
EPS Growth (%) arrow
23.44 2.70 -30.51 -42.60 -16.64
Book Value Growth (%) arrow
21.86 16.51 15.41 5.13 13.54

Valuation Ratios

 Vijaya Diagno Global Health Dr. Lal Pathlabs Krishna Institute Metropolis Health
Price / Earnings arrow
79.61 69.04 45.29 145.70 23.90
Price / Book Value arrow
14.85 9.62 12.40 8.54 7.82
Dividend Yield (%) arrow
0.14 0.03 1.06 0.00 0.85
EV/EBITDA arrow
40.54 39.89 37.09 42.61 28.45
Market Cap (₹ Cr) arrow
8,864.05 25,841.07 22,015.15 24,901.98 8,992.90

Solvency Ratios

 Vijaya Diagno Global Health Dr. Lal Pathlabs Krishna Institute Metropolis Health
Debt to Equity arrow
0.00 0.15 0.00 1.19 0.00
Short term debt to equity ratio arrow
-- -- -- 0.15 0.01
Current Ratio arrow
2.60 2.67 3.48 0.76 1.40
Quick Ratio arrow
2.56 2.54 3.38 0.68 1.27
Interest Coverage arrow
7.84 8.83 30.37 2.08 11.80

Operating Efficiency Ratios

 Vijaya Diagno Global Health Dr. Lal Pathlabs Krishna Institute Metropolis Health
Debtors to sales (%) arrow
2.43 8.78 3.83 13.16 9.96
Asset Turnover arrow
0.62 0.88 0.99 0.62 0.85
Receivable days arrow
7.98 29.09 13.13 44.38 35.29
Inventory Days arrow
2.20 6.05 5.28 7.52 10.35
Payable days arrow
136.27 80.04 118.67 133.54 143.56
Cash Conversion Cycle arrow
-126.08 -44.90 -100.26 -81.64 -97.92
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...